Global initiative encourages sharing disease info to combat outbreaks

In the event of a global pandemic, international sharing of data would be crucial in saving the human race. For now, researchers can agree that the Global Initiative on Sharing All Influenza Data (GISAID) shows just how improved international sharing of data could protect people in the event of an infectious disease outbreak.

In such an event, nations around the globe should be able to come together and join scientific communities to share information regarding the disease. The GISAID was the first step in international disease information sharing and researchers compiled five steps, following GISAID’s methods, to improve global health including:

  1. Bring together a complete record of high-quality information of influenza from around the world.
  2. Develop a process to rapidly share information for outbreaks.
  3. Support the World Health Organizations selection process for the top seasonal flu strain.
  4. Develop problem-solving methods for potential barriers to the sharing of disease data.
  5. Reinforcing the trust between countries important to the global pandemic preparedness.

"How to encourage the rapid international sharing of scientific data about deadly pathogens is a major global health challenge for the twenty-first century. There are important lessons that can be learned from the influenza community, which has developed an innovative model for sharing such data over the past decade," said Stefan Elbe, co-author of the Global Challenges article.

""
Cara Livernois, News Writer

Cara joined TriMed Media in 2016 and is currently a Senior Writer for Clinical Innovation & Technology. Originating from Detroit, Michigan, she holds a Bachelors in Health Communications from Grand Valley State University.

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup